| abstract |
The present invention relates to a glucagon peptide agonist having improved solubility and stability, the use of said peptide in therapy, a therapeutic method comprising administering said peptide to a patient in need thereof, and the use of said peptide in the manufacture of a medicament Regarding use. The glucagon peptides of the present invention are particularly important for the treatment of various diseases or conditions associated with hypoglycemia, diabetes and obesity, as well as hypoglycemia, diabetes and obesity. |